Teen cigarette smoking declining more slowly in rural U.S.
(Reuters Health) – The odds of smoking for U.S. adolescents are 50 percent higher in rural areas than in urban areas, even as rates of teen smoking in both settings…
Pinterest seeks $15-$17 per share in IPO, below last private valuation
(Reuters) – Pinterest Inc on Monday set a price range of $15 to $17 per share for its initial public offering of 75 million shares, valuing it below the $12…
S&P 500, Nasdaq edge higher as earnings season looms
NEW YORK (Reuters) – The S&P 500 and the Nasdaq edged into positive territory on Monday, with gains held in check by falling industrials as investors braced for what analysts…
S&P 500, Nasdaq edge higher as earnings season looms
NEW YORK (Reuters) – The S&P 500 and the Nasdaq edged into positive territory on Monday, with gains held in check by falling industrials as investors braced for what analysts…
Zogenix’s seizure drug filing fails to pass U.S. FDA scrutiny
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s treatment for seizures associated with Dravet syndrome, a rare form…
Factbox: Who are PG&E's new directors?
PG&E Corp on Wednesday appointed Tennessee Valley Authority Chief Executive Officer William Johnson as its CEO and added 10 members to its board of directors, as the company navigates through…
PG&E names TVA’s William Johnson as CEO, reshuffles board
FILE PHOTO: Pacific Gas and Electric (PG&E) trucks are seen parked on a road between homes destroyed by the Tubbs Fire in Santa Rosa, California, U.S., October 11, 2017. REUTERS/Stephen…
Image sharing website Pinterest files for IPO
FILE PHOTO: A Pinterest banner hangs on the facade of the New York Stock Exchange (NYSE) in New York City, U.S., September 22, 2017. REUTERS/Brendan McDermid (Reuters) – Pinterest Inc,…
Wall Street tumbles on global economic slowdown fears
NEW YORK (Reuters) – Wall Street stocks sold off sharply on Friday, with all three major U.S. stock indexes posting their biggest one-day percentage declines since Jan. 3, as weak…
Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find…